Haddadin Yezan Munther: insider buys
Every open-market stock purchase reported by Haddadin Yezan Munther to the SEC on Form 4.
Total bought$39.03K
Purchases2
Companies1
Last purchase filedJun 3, 2026
Return on these buys-29%
Haddadin Yezan Munther has made 2 open-market purchases worth $39.03K in 1 company since May 27, 2026, according to SEC Form 4 filings. The most recent was filed on Jun 3, 2026: 29,000 shares of OTLK at $0.83 (Director), worth $24.07K. Taken together, these purchases are down 29% at the latest closing prices (split-adjusted, weighted by amount).
Companies Haddadin Yezan Munther bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Director | 2 | $39.03K | -29% | Jun 3 |
Get the next Haddadin Yezan Munther purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3 | OTLKOutlook Therapeutics, Inc. | Haddadin Yezan MuntherDirector | $24.07K | 29,000 | $0.83 | -47% | +78% | Jun 2 | SEC |
| May 27 | OTLKOutlook Therapeutics, Inc. | Haddadin Yezan MuntherDirector | $14.96K | 34,000 | $0.44 | -0.2% | >+999% | May 26 | SEC |